These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24601543)

  • 1. Retro-inversal of intracellular selected β-amyloid-interacting peptides: implications for a novel Alzheimer's disease treatment.
    Acerra N; Kad NM; Griffith DA; Ott S; Crowther DC; Mason JM
    Biochemistry; 2014 Apr; 53(13):2101-11. PubMed ID: 24601543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular selection of peptide inhibitors that target disulphide-bridged Aβ42 oligomers.
    Acerra N; Kad NM; Cheruvara H; Mason JM
    Protein Sci; 2014 Sep; 23(9):1262-74. PubMed ID: 24947815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining intracellular selection with protein-fragment complementation to derive Aβ interacting peptides.
    Acerra N; Kad NM; Mason JM
    Protein Eng Des Sel; 2013 Jul; 26(7):463-70. PubMed ID: 23708321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease.
    Matharu B; El-Agnaf O; Razvi A; Austen BM
    Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer's disease.
    Parthsarathy V; McClean PL; Hölscher C; Taylor M; Tinker C; Jones G; Kolosov O; Salvati E; Gregori M; Masserini M; Allsop D
    PLoS One; 2013; 8(1):e54769. PubMed ID: 23382963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure.
    Kokkoni N; Stott K; Amijee H; Mason JM; Doig AJ
    Biochemistry; 2006 Aug; 45(32):9906-18. PubMed ID: 16893191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
    ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of Si Nanowires against A
    Zhao X; Mou C; Xu J; Cui W; Shi Y; Wang Y; Luo T; Guo W; Ye J; Chen W
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S; Nehru B; Saini A
    Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peptide that binds specifically to the β-amyloid of Alzheimer's disease: selection and assessment of anti-β-amyloid neurotoxic effects.
    Wang F; Zhou XL; Yang QG; Xu WH; Wang F; Chen YP; Chen GH
    PLoS One; 2011; 6(11):e27649. PubMed ID: 22102917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substoichiometric inhibition of Abeta(1-40) aggregation by a tandem Abeta(40-1-Gly8-1-40) peptide.
    Mustafi SM; Garai K; Crick SL; Baban B; Frieden C
    Biochem Biophys Res Commun; 2010 Jul; 397(3):509-12. PubMed ID: 20515649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationally designed peptidomimetic modulators of aβ toxicity in Alzheimer's disease.
    Rajasekhar K; Suresh SN; Manjithaya R; Govindaraju T
    Sci Rep; 2015 Jan; 5():8139. PubMed ID: 25633824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
    Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
    Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-helix targeting reduces amyloid-beta peptide toxicity.
    Nerelius C; Sandegren A; Sargsyan H; Raunak R; Leijonmarck H; Chatterjee U; Fisahn A; Imarisio S; Lomas DA; Crowther DC; Strömberg R; Johansson J
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9191-6. PubMed ID: 19458258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
    Kaneko I; Morimoto K; Kubo T
    Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-assembly of N-terminal Alzheimer's β-amyloid and its inhibition.
    Prasanna G; Jing P
    Biochem Biophys Res Commun; 2021 Jan; 534():950-956. PubMed ID: 33143872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
    Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
    J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.